• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ezh2 控制自然杀伤 T 细胞的发育,而这些细胞会导致自发性哮喘样病变。

Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology.

机构信息

Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia.

Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.

出版信息

J Allergy Clin Immunol. 2019 Aug;144(2):549-560.e10. doi: 10.1016/j.jaci.2019.02.024. Epub 2019 Mar 7.

DOI:10.1016/j.jaci.2019.02.024
PMID:30851295
Abstract

BACKGROUND

Natural killer T (NKT) cells express a T-cell receptor that recognizes endogenous and environmental glycolipid antigens. Several subsets of NKT cells have been identified, including IFN-γ-producing NKT1 cells, IL-4-producing NKT2 cells, and IL-17-producing NKT17 cells. However, little is known about the factors that regulate their differentiation and respective functions within the immune system.

OBJECTIVE

We sought to determine whether the polycomb repressive complex 2 protein enhancer of zeste homolog 2 (Ezh2) restrains pathogenicity of NKT cells in the context of asthma-like lung disease.

METHODS

Numbers of invariant natural killer T (iNKT) 1, iNKT2, and iNKT17 cells and tissue distribution, cytokine production, lymphoid tissue localization, and transcriptional profiles of iNKT cells from wild-type and Ezh2 knockout (KO) iNKT mice were determined. The contribution of NKT cells to development of spontaneous and house dust mite-induced airways pathology, including airways hyperreactivity (AHR) to methacholine, was also assessed in wild-type, Ezh2 KO, and Ezh2 KO mice lacking NKT cells.

RESULTS

Ezh2 restrains development of pathogenic NKT cells, which induce spontaneous asthma-like disease in mice. Deletion of Ezh2 increased production of IL-4 and IL-13 and induced spontaneous AHR, lung inflammation, mucus production, and IgE. Increased IL-4 and IL-13 levels, AHR, lung inflammation, and IgE levels were all dependent on iNKT cells. In house dust mite-exposed animals Ezh2 KO resulted in enhanced AHR that was also dependent on iNKT cells.

CONCLUSION

Ezh2 is a central regulator of iNKT pathogenicity and suppresses the ability of iNKT cells to induce asthma-like pathology.

摘要

背景

自然杀伤 T (NKT) 细胞表达一种 T 细胞受体,可识别内源性和环境糖脂抗原。已经鉴定出几种 NKT 细胞亚群,包括产生 IFN-γ 的 NKT1 细胞、产生 IL-4 的 NKT2 细胞和产生 IL-17 的 NKT17 细胞。然而,对于调节其在免疫系统中的分化和各自功能的因素知之甚少。

目的

我们试图确定多梳抑制复合物 2 蛋白增强子的锌指蛋白 2 (Ezh2) 是否在哮喘样肺部疾病的情况下抑制 NKT 细胞的致病性。

方法

测定野生型和 Ezh2 敲除 (KO) iNKT 小鼠中不变自然杀伤 T (iNKT) 1、iNKT2 和 iNKT17 细胞的数量以及组织分布、细胞因子产生、淋巴组织定位和 iNKT 细胞的转录谱。还评估了 NKT 细胞对自发性和屋尘螨诱导的气道病理,包括对乙酰甲胆碱的气道高反应性 (AHR) 的贡献,在野生型、Ezh2 KO 和缺乏 NKT 细胞的 Ezh2 KO 小鼠中进行了评估。

结果

Ezh2 抑制致病性 NKT 细胞的发育,这些细胞在小鼠中诱导自发性哮喘样疾病。Ezh2 的缺失增加了 IL-4 和 IL-13 的产生,并诱导了自发性 AHR、肺炎症、粘液产生和 IgE。增加的 IL-4 和 IL-13 水平、AHR、肺炎症和 IgE 水平均依赖于 iNKT 细胞。在屋尘螨暴露的动物中,Ezh2 KO 导致增强的 AHR,这也依赖于 iNKT 细胞。

结论

Ezh2 是 iNKT 致病性的核心调节剂,可抑制 iNKT 细胞诱导哮喘样病理的能力。

相似文献

1
Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology.Ezh2 控制自然杀伤 T 细胞的发育,而这些细胞会导致自发性哮喘样病变。
J Allergy Clin Immunol. 2019 Aug;144(2):549-560.e10. doi: 10.1016/j.jaci.2019.02.024. Epub 2019 Mar 7.
2
IL-9 Expression by Invariant NKT Cells Is Not Imprinted during Thymic Development.不变自然杀伤T细胞的IL-9表达在胸腺发育过程中未被印记。
J Immunol. 2015 Oct 1;195(7):3463-71. doi: 10.4049/jimmunol.1403170. Epub 2015 Aug 21.
3
Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets.丝氨酸蛋白酶抑制剂 B1A(Serpinb1a)对于固有自然杀伤 T 细胞亚群的发育和细胞因子反应是可有可无的。
Front Immunol. 2020 Nov 11;11:562587. doi: 10.3389/fimmu.2020.562587. eCollection 2020.
4
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.先天淋巴细胞对 IL-33 的反应独立于适应性免疫介导气道高反应性。
J Allergy Clin Immunol. 2012 Jan;129(1):216-27.e1-6. doi: 10.1016/j.jaci.2011.10.036. Epub 2011 Nov 25.
5
The invariant natural killer T cell-mediated chemokine X-C motif chemokine ligand 1-X-C motif chemokine receptor 1 axis promotes allergic airway hyperresponsiveness by recruiting CD103 dendritic cells.不变自然杀伤 T 细胞介导的趋化因子 X-C 基序趋化因子配体 1-X-C 基序趋化因子受体 1 轴通过募集 CD103 树突状细胞促进过敏性气道高反应性。
J Allergy Clin Immunol. 2018 Dec;142(6):1781-1792.e12. doi: 10.1016/j.jaci.2017.12.1005. Epub 2018 Feb 21.
6
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.PD-L1 和 PD-L2 以相反的方式调节气道炎症和 iNKT 细胞依赖性气道高反应性。
Mucosal Immunol. 2010 Jan;3(1):81-91. doi: 10.1038/mi.2009.112. Epub 2009 Sep 9.
7
Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation.维生素 D 受体敲除小鼠中不变自然杀伤 T 细胞缺陷可预防实验性肺部炎症。
J Immunol. 2011 Nov 1;187(9):4907-12. doi: 10.4049/jimmunol.1101519. Epub 2011 Sep 23.
8
Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation.在整个发育过程以及2型炎症环境中,不变自然杀伤T细胞的细胞因子表达受到严格调控。
Mucosal Immunol. 2016 May;9(3):597-609. doi: 10.1038/mi.2015.78. Epub 2015 Sep 9.
9
Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.前沿:在实验性哮喘模型中,不变性Vα14自然杀伤T细胞是变应原诱导的气道炎症和高反应性所必需的。
J Immunol. 2003 Aug 15;171(4):1637-41. doi: 10.4049/jimmunol.171.4.1637.
10
β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation.β-连环蛋白是增强白细胞介素-25依赖性肺部炎症的iNKT2和iNKT17细胞分化所必需的。
BMC Immunol. 2015 Oct 19;16:62. doi: 10.1186/s12865-015-0121-0.

引用本文的文献

1
Decoding innate lymphoid cells and innate-like lymphocytes in asthma: pathways to mechanisms and therapies.解析哮喘中的固有淋巴细胞和固有样淋巴细胞:从途径到机制与治疗
J Biomed Sci. 2025 May 12;32(1):48. doi: 10.1186/s12929-025-01142-w.
2
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases.EZH2在鼻部疾病中的作用机制及治疗意义
Clin Rev Allergy Immunol. 2025 May 5;68(1):46. doi: 10.1007/s12016-025-09058-x.
3
Ezh2 Shapes T Cell Plasticity to Drive Atherosclerosis.Ezh2塑造T细胞可塑性以驱动动脉粥样硬化。
Circulation. 2025 May 13;151(19):1391-1408. doi: 10.1161/CIRCULATIONAHA.124.072384. Epub 2025 Feb 7.
4
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.CAR-NKT 细胞在哮喘中的应用:NKT 作为 CAR 治疗有前途的细胞的应用。
Clin Rev Allergy Immunol. 2024 Jun;66(3):328-362. doi: 10.1007/s12016-024-08998-0. Epub 2024 Jul 12.
5
Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies.自然杀伤 T 细胞在过敏性哮喘中的作用:对新型免疫治疗策略发展的启示。
Front Immunol. 2024 Apr 2;15:1364774. doi: 10.3389/fimmu.2024.1364774. eCollection 2024.
6
Contribution of NKT cells and CD1d-expressing cells in obesity-associated adipose tissue inflammation.NKT 细胞和 CD1d 表达细胞在肥胖相关性脂肪组织炎症中的作用。
Front Immunol. 2024 Feb 15;15:1365843. doi: 10.3389/fimmu.2024.1365843. eCollection 2024.
7
Lonicerin alleviates ovalbumin-induced asthma of mice via inhibiting enhancer of zeste homolog 2/nuclear factor-kappa B signaling pathway.野罂粟苷通过抑制增强子结合蛋白 2/核因子-κB 信号通路减轻卵清蛋白诱导的哮喘小鼠模型的气道炎症反应。
Exp Anim. 2024 May 3;73(2):154-161. doi: 10.1538/expanim.23-0068. Epub 2023 Nov 10.
8
Gene-Smoking Interaction Analysis for the Identification of Novel Asthma-Associated Genetic Factors.基因-吸烟相互作用分析鉴定新的哮喘相关遗传因素。
Int J Mol Sci. 2023 Jul 31;24(15):12266. doi: 10.3390/ijms241512266.
9
Mutational pattern off homologous recombination repair (HRR)-related genes in upper tract urothelial carcinoma.上尿路上皮癌同源重组修复(HRR)相关基因的突变模式。
Cancer Med. 2023 Jul;12(14):15304-15316. doi: 10.1002/cam4.6175. Epub 2023 Jun 30.
10
An automated multi-modal graph-based pipeline for mouse genetic discovery.基于自动化多模态图的小鼠遗传发现管道。
Bioinformatics. 2022 Jun 27;38(13):3385-3394. doi: 10.1093/bioinformatics/btac356.